Full name
OLIDENT POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
32.50.Z - Production of medical devices, instruments, and products, including dental products
20.59.Z - Manufacture of other chemical products, not elsewhere classified
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.90.Z - Non-specialized wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,8 | 2,3 | 0,7 | -67,7 |
Gross profit (loss) | 1,8 | 2,3 | 0,7 | -67,5 |
EBITDA | 0,6 | |||
Short time liabilities | 0,8 | 0,4 | 0 | -99,3 |
Other operating costs | 0 | 0 | 0 | -100 |
Equity capital | 0,8 | 0,2 | 0,2 | 14,4 |
Operating profit (EBIT) | 0,7 | |||
Assets | 5,8 | 4,9 | 0,2 | -95,5 |
Net profit (loss) | 1,8 | 2,3 | 0,7 | -70 |
Cash | 0,1 | 0 | 0,1 | 159,1 |
Liabilities and provisions for liabilities | 5 | 4,7 | 0 | -99,9 |
Net income from sale | 7,8 | 8,6 | 4,1 | -51,9 |
Working assets | 3,4 | 2,6 | 0,2 | -91,6 |
Other income costs | 0 | |||
Depreciation | 0,1 | 0,1 | 2,3 | 3200 |
% | % | % | p.p. | |
Profitability of capital | 215,8 | 1192,9 | 312,4 | -880,5 |
Equity capital to total assets | 14,1 | 3,8 | 98,9 | 95,1 |
Gross profit margin | 22,6 | 26,7 | 18 | -8,7 |
EBITDA Margin | 2,2 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 37 | 15 | 0 | -15 |
Current financial liquidity indicator | 4.350584506988525 | 7.3134331703186035 | 87.89433288574219 | 80,6 |
Net dept to EBITDA | 0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane